Angiotensin II Type 1 Receptor Antagonist Azilsartan Restores Vascular Reactivity Through a Perivascular Adipose Tissue-Independent Mechanism in Rats with Metabolic Syndrome Satomi KagotaKana Maruyama-FumotoKazumasa Shinozuka ORIGINAL ARTICLE 16 August 2019 Pages: 501 - 509
Trends for and Clinical Factors Associated with Choice of Oral P2Y12 Inhibitors for Patients on Chronic Dialysis Nishank JainSuzanne L. HuntRafia S. Rasu ORIGINAL ARTICLE Open access 15 November 2019 Pages: 511 - 521
Bleeding Risk Scores and Scales of Frailty for the Prediction of Haemorrhagic Events in Older Adults with Acute Coronary Syndrome: Insights from the FRASER study Rita PavasiniElisa MaiettiGianluca Campo ORIGINAL ARTICLE 23 September 2019 Pages: 523 - 532
Cost-Effectiveness of Strategies to Personalize the Selection of P2Y12 Inhibitors in Patients with Acute Coronary Syndrome Kibum KimDaniel R. TouchetteRobert J. DiDomenico ORIGINAL ARTICLE 31 July 2019 Pages: 533 - 546
Effects of Dipeptidyl Peptidase-4 Inhibitor Linagliptin on Left Ventricular Dysfunction in Patients with Type 2 Diabetes and Concentric Left Ventricular Geometry (the DYDA 2™ Trial). Rationale, Design, and Baseline Characteristics of the Study Population Carlo Bruno GiordaGiovanni Cioffion behalf of DYDA 2 Investigators ORIGINAL ARTICLE 15 August 2019 Pages: 547 - 555
Five-Year Outcomes of Biodegradable Polymer Drug-Eluting Stents Versus Second-Generation Durable Polymer Drug-Eluting Stents: a Meta-Analysis of Randomized Controlled Trials Yake LouYing YuXiaomin Nie ORIGINAL ARTICLE 26 November 2019 Pages: 557 - 566
The Associations of Diuretics and Laxatives Use with Cardiovascular Mortality. An Individual Patient-Data Meta-analysis of Two Large Cohort Studies Liesa Katharina HoppeDana Clarissa MuhlackBen Schöttker ORIGINAL ARTICLE Open access 02 August 2019 Pages: 567 - 579
Impact of Ca2+-Sensitive Potassium Channels in Levosimendan-Induced Postconditioning Martin StroethoffSebastian BunteStephan U. Sixt ORIGINAL ARTICLE 08 November 2019 Pages: 581 - 588
Pathophysiology, Diagnosis, and Management of the No-Reflow Phenomenon Joseph AllencherrilHani JneidYochai Birnbaum REVIEW ARTICLE 15 August 2019 Pages: 589 - 597
Cardiovascular Effects of Urocortin-2: Pathophysiological Mechanisms and Therapeutic Potential Cláudia Monteiro-PintoRui AdãoCarmen Brás-Silva ORIGINAL ARTICLE 11 September 2019 Pages: 599 - 613
Impact of Polypharmacy and P-Glycoprotein- and CYP3A4-Modulating Drugs on Safety and Efficacy of Oral Anticoagulation Therapy in Patients with Atrial Fibrillation Ralf E. HarskampMartina TeichertRenato D. Lopes REVIEW ARTICLE Open access 13 September 2019 Pages: 615 - 623
State of the Art Comprehensive Review of Individual Statins, Their Differences, Pharmacology, and Clinical Implications Veronica AzemawahMohammad Reza MovahedMehrnoosh Hashemzadeh REVIEW ARTICLE 26 November 2019 Pages: 625 - 639